OLMA Annual Cash & Cash Equivalents
$68.54 M
+$44.84 M+189.17%
31 December 2023
Summary:
As of January 23, 2025, OLMA annual cash & cash equivalents is $68.54 million, with the most recent change of +$44.84 million (+189.17%) on December 31, 2023. During the last 3 years, it has fallen by -$270.01 million (-79.76%). OLMA annual cash & cash equivalents is now -79.76% below its all-time high of $338.55 million, reached on December 31, 2020.OLMA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OLMA Quarterly Cash And Cash Equivalents
$35.89 M
+$19.00 M+112.46%
30 September 2024
Summary:
As of January 23, 2025, OLMA quarterly cash and cash equivalents is $35.89 million, with the most recent change of +$19.00 million (+112.46%) on September 30, 2024. Over the past year, it has dropped by -$81.52 million (-69.43%). OLMA quarterly cash and cash equivalents is now -89.40% below its all-time high of $338.55 million, reached on December 31, 2020.OLMA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OLMA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +189.2% | -69.4% |
| 3 y3 years | -79.8% | -69.4% |
| 5 y5 years | +2076.5% | -69.4% |
OLMA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +396.2% | -69.4% | +159.8% |
| 5 y | 5-year | -79.8% | >+9999.0% | -89.4% | >+9999.0% |
| alltime | all time | -79.8% | >+9999.0% | -89.4% | >+9999.0% |
Olema Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $35.89 M(+112.5%) |
| June 2024 | - | $16.89 M(-49.9%) |
| Mar 2024 | - | $33.72 M(-50.8%) |
| Dec 2023 | $68.54 M(+189.2%) | $68.54 M(-41.6%) |
| Sept 2023 | - | $117.41 M(+235.9%) |
| June 2023 | - | $34.96 M(-14.6%) |
| Mar 2023 | - | $40.92 M(+72.6%) |
| Dec 2022 | $23.70 M | $23.70 M(-11.6%) |
| Sept 2022 | - | $26.80 M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $24.53 M(+14.0%) |
| Mar 2022 | - | $21.51 M(+55.7%) |
| Dec 2021 | $13.81 M(-95.9%) | $13.81 M(-46.0%) |
| Sept 2021 | - | $25.60 M(-49.2%) |
| June 2021 | - | $50.42 M(+5.3%) |
| Mar 2021 | - | $47.88 M(-85.9%) |
| Dec 2020 | $338.55 M(>+9900.0%) | $338.55 M(+164.9%) |
| Sept 2020 | - | $127.82 M(>+9900.0%) |
| Dec 2019 | $68.00 K(-97.8%) | $68.00 K |
| Dec 2018 | $3.15 M | - |
FAQ
- What is Olema Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Olema Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Olema Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of OLMA is $68.54 M
What is the all time high annual cash & cash equivalents for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual cash & cash equivalents is $338.55 M
What is Olema Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, OLMA annual cash & cash equivalents has changed by +$44.84 M (+189.17%)
What is Olema Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OLMA is $35.89 M
What is the all time high quarterly cash and cash equivalents for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly cash and cash equivalents is $338.55 M
What is Olema Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, OLMA quarterly cash and cash equivalents has changed by -$81.52 M (-69.43%)